In a 79-year-old man taking sildenafil (phosphodiesterase‑5 inhibitor) for erectile dysfunction who achieves an erection but cannot achieve orgasm, how should I manage this as his primary care physician?

Management of Anorgasmia in a 79-Year-Old Man on Sildenafil

This patient has delayed ejaculation (DE) or anorgasmia, not erectile dysfunction—sildenafil treats erections but does not directly address orgasm or ejaculation, and you need to shift your management approach accordingly. 1

Understanding the Problem

Your patient achieves erections with sildenafil but cannot reach orgasm or ejaculate. This is a distinct sexual dysfunction from ED. Sildenafil and other PDE5 inhibitors improve erectile function through the nitric oxide pathway but do not directly facilitate orgasm or ejaculation 2. Age is one of the most significant risk factors for DE, likely combining both psychological and physiological processes 1.

Initial Workup

Check morning testosterone levels first—this is the single most important lab test, as low testosterone is directly associated with delayed ejaculation and anorgasmia, particularly in older men 1. The AUA/SMSNA guideline specifically supports this testing.

Additional basic labs to consider:

• Fasting glucose and lipid panel
• Thyroid-stimulating hormone
• Electrolytes, glycosylated hemoglobin (to assess for neuropathy risk from diabetes or vascular disease) 1

Review his medication list carefully—many drugs cause delayed ejaculation, including:

• SSRIs and other antidepressants
• Antihypertensives (especially alpha-blockers, beta-blockers)
• Antipsychotics
• Opioids

Treatment Algorithm

First-Line: Behavioral and Lifestyle Modifications

Advise him to modify sexual positions or practices to increase arousal—this is a low-risk, guideline-recommended intervention that may help trigger orgasmic response 1. This includes:

• Incorporating alternative sexual practices or scripts
• Using sexual enhancement devices
• Opening communication with his partner about sexual needs and desires

Second-Line: Testosterone Replacement (if indicated)

If testosterone is low, offer testosterone replacement therapy—this improves both ED and orgasmic function in hypogonadal men 1. However, you must monitor:

• Hemoglobin levels (polycythemia risk)
• Liver function tests
• PSA levels (prostate cancer risk)

Third-Line: Medication Adjustments

If he's on medications contributing to DE, suggest dose adjustment, replacement, or staged cessation 1. This is a clinical principle in the AUA/SMSNA guideline.

Fourth-Line: Consider Referral

Refer to a mental health professional with expertise in sexual health—particularly for lifelong or acquired DE that doesn't respond to initial interventions 1. Psycho-behavioral strategies enhance psychosexual arousal and remove barriers to sexual excitement, which is especially relevant in age-related increases in ejaculatory latency.

Fifth-Line: Pharmacotherapy (Off-Label, Limited Evidence)

If the above fail, consider off-label pharmacotherapy, though evidence is limited 1:

PRN options (taken before sex):

• Pseudoephedrine 60-120 mg (120-150 minutes prior)
• Ephedrine 15-60 mg (1 hour prior)
• Oxytocin 24 IU intranasal during sex

Daily options:

• Bethanecol 20 mg daily
• Yohimbine 5.4 mg three times daily
• Cabergoline 0.25-2 mg twice weekly

Critical Pitfalls to Avoid

1. Don't just increase the sildenafil dose—PDE5 inhibitors treat erections, not orgasm. Continuing to escalate sildenafil won't address his actual problem 2.

2. Don't assume this is "normal aging"—while age increases DE risk, it's treatable and significantly impacts quality of life for both partners 1.

3. Don't overlook medication side effects—this is one of the most common and reversible causes of DE 1.

4. Don't forget partner involvement—opening communication between partners is essential for treatment success 1.

Key Counseling Points

Explain to your patient that:

• His erections are working (thanks to sildenafil), but orgasm/ejaculation is a separate neurological process
• This is a recognized medical condition called delayed ejaculation, not a failure of the sildenafil
• Age is a major contributing factor, but treatment options exist
• Behavioral modifications and potentially testosterone replacement (if low) are the safest, most evidence-based approaches
• The condition impacts both him and his partner, so involving her in discussions may be beneficial